Showing results (361-370 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1993
The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapyA M Jackson, S Prescott, S J Hawkyard, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1994
In vivo regulation of transforming growth factor beta 1 transcription by immunotherapy: interleukin-2 impairs interferon-alpha-stimulated increase in steady-state mRNA levels of transforming growth factor beta 1B Jahn, J Brieger, K Fenchel, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1994
Lysis of endothelial cells by autologous lymphokine-activated killer cellsJ Kitayama, N Tsuno, H Yasuhara, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1994
Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivoG J Dougherty, J D Thacker, R S Lavey, et al.Cancer Immunology, Immunotherapy : CII|April 1, 1994
Role of macrophages in the host response to Lewis lung peritoneal carcinomatosisM W Barth, P S MorahanCancer Immunology, Immunotherapy : CII|July 1, 1994
Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinomaF W Hill, V P Rutten, M H Hoyer, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1994
Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2M B Leger-Ravet, C Mathiot, A Portier, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1994
In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cellsJ Hald, N Rasmussen, M H ClaessonCancer Immunology, Immunotherapy : CII|December 1, 1994
Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapyK M McAveney, L G Gomella, E C LattimeCancer Immunology, Immunotherapy : CII|March 1, 1994
Induction of an immune network cascade in cancer patients treated with monoclonal antibodies (ab1). II. Is induction of anti-idiotype reactive T cells (T3) of importance for tumor response to mAb therapy?J Fagerberg, J E Frödin, P Ragnhammar, et al.Pageof 650